SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PACIARONI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.521
AS - Asia 6.039
EU - Europa 3.589
SA - Sud America 1.298
Continente sconosciuto - Info sul continente non disponibili 540
AF - Africa 235
OC - Oceania 41
Totale 19.263
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.978
IT - Italia 1.903
SG - Singapore 1.596
BD - Bangladesh 1.543
BR - Brasile 951
CN - Cina 704
HK - Hong Kong 703
VN - Vietnam 631
NL - Olanda 359
CA - Canada 333
FR - Francia 200
DE - Germania 198
JP - Giappone 180
GB - Regno Unito 173
IN - India 147
FI - Finlandia 124
AR - Argentina 113
RU - Federazione Russa 93
MX - Messico 79
ZA - Sudafrica 74
EC - Ecuador 73
ES - Italia 72
UA - Ucraina 72
ID - Indonesia 69
BE - Belgio 58
IQ - Iraq 56
AE - Emirati Arabi Uniti 55
PL - Polonia 55
TR - Turchia 51
AT - Austria 47
PT - Portogallo 47
CO - Colombia 46
PK - Pakistan 46
JM - Giamaica 43
EG - Egitto 41
AU - Australia 37
SE - Svezia 35
VE - Venezuela 34
HU - Ungheria 32
MY - Malesia 31
TW - Taiwan 30
IE - Irlanda 29
MA - Marocco 28
PH - Filippine 27
UZ - Uzbekistan 26
CL - Cile 25
SA - Arabia Saudita 24
CR - Costa Rica 23
PY - Paraguay 21
TN - Tunisia 21
CH - Svizzera 16
PE - Perù 16
KE - Kenya 15
NP - Nepal 15
BO - Bolivia 13
DZ - Algeria 13
KZ - Kazakistan 13
NI - Nicaragua 13
NO - Norvegia 13
ET - Etiopia 12
HN - Honduras 11
IL - Israele 11
JO - Giordania 10
LT - Lituania 10
AZ - Azerbaigian 9
DO - Repubblica Dominicana 8
OM - Oman 8
CZ - Repubblica Ceca 7
IR - Iran 7
RO - Romania 7
TT - Trinidad e Tobago 7
PA - Panama 6
TH - Thailandia 6
UY - Uruguay 6
AL - Albania 5
AM - Armenia 5
BB - Barbados 5
GR - Grecia 5
HR - Croazia 5
KG - Kirghizistan 5
NG - Nigeria 5
PS - Palestinian Territory 5
RS - Serbia 5
BY - Bielorussia 4
GT - Guatemala 4
KR - Corea 4
LA - Repubblica Popolare Democratica del Laos 4
PR - Porto Rico 4
AO - Angola 3
BG - Bulgaria 3
CG - Congo 3
DK - Danimarca 3
GE - Georgia 3
LV - Lettonia 3
LY - Libia 3
TZ - Tanzania 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CD - Congo 2
Totale 18.685
Salva come PNG Salva come JPEG
Città #
San Jose 966
Ashburn 938
Singapore 825
Hong Kong 696
Council Bluffs 636
New York 547
Los Angeles 308
Dallas 302
Ho Chi Minh City 208
Beijing 207
Milan 201
Tokyo 169
Hanoi 163
Chicago 143
Santa Clara 141
Rome 129
Buffalo 122
Amsterdam 97
Toronto 95
Bologna 92
São Paulo 81
Helsinki 73
Naples 71
Lauterbourg 70
Orem 70
Montreal 65
Phoenix 56
Utrecht 53
Atlanta 51
San Francisco 50
Hefei 48
Warsaw 48
Denver 47
Turin 47
Florence 43
Quito 41
Abu Dhabi 39
Groningen 38
Lisbon 38
Mexico City 38
Brooklyn 37
Figino 37
Bari 36
Frankfurt am Main 36
Lappeenranta 36
Boston 33
Da Nang 33
Nuremberg 33
Poplar 32
Haiphong 31
Palermo 31
Budapest 30
Houston 30
Paris 29
Baghdad 28
Barcelona 28
Mulhouse 28
Vancouver 28
Boardman 27
Charlotte 27
Salt Lake City 27
Stockholm 27
De Lier 26
Dublin 26
Seattle 26
Miami 25
Cairo 24
Des Moines 24
Belo Horizonte 23
Dhaka 23
Ferrara 23
London 23
Rio de Janeiro 23
Taichung 23
Tampa 22
Tashkent 22
Curitiba 21
Johannesburg 21
Sydney 21
Pasadena 20
Hải Dương 19
Philadelphia 19
Falkenstein 18
Guayaquil 18
Memphis 18
Shanghai 18
Washington 18
Brasília 17
Chennai 17
Kingston 17
Kuala Lumpur 17
Madrid 17
Naaldwijk 17
Padua 17
Venice 17
Hangzhou 16
Jakarta 16
Genoa 15
Guarulhos 15
Munich 15
Totale 9.493
Salva come PNG Salva come JPEG
Nome #
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 1.161
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 574
Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke 361
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 242
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 205
Desmoteplase 194
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 179
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation 171
Association Between Migraine and Cervical Artery Dissection The Italian Project on Stroke in Young Adults 165
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging – Results from the READAPT study 161
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin 151
15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry 150
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 148
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: The MUCH Italy 142
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 141
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage 139
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 134
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 130
Prevention of venous thromboembolism in immobilized neurological patients: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 125
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 120
Age- and sex-specific analysis of patients with embolic stroke of undetermined source 120
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 120
Un caffè tra due amici al bar. L'esame obiettivo neurologico 118
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 117
Long-term outcome of cervical artery dissection : IPSYS CeAD: study protocol, rationale, and baseline data of an Italian multicenter research collaboration 113
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial 112
Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis 112
Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy 111
Long-Term Risk of Recurrent Cervical Artery Dissection and Stroke After Pregnancy 110
Intravenous thrombolysis in patients with acute ischaemic stroke and active cancer (the ITACA-stroke study) 109
Treatments in Ischemic Stroke: Current and Future 109
Anticoagulation Strategies Following Breakthrough Ischemic Stroke While on Direct Anticoagulants: A Meta-Analysis 108
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 107
A tool to identify patients with embolic stroke of undetermined source at high recurrence risk 106
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome 106
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 106
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT Study 103
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection 103
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis 101
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 100
Risk Profile of Patients with Spontaneous Cervical Artery Dissection 99
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 97
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 96
History of stroke 94
Consensus paper on the management of acute isolated vertigo in the emergency department 94
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome 93
Medical versus neurosurgical treatment in ICH patients: a single center experience 93
Secondary stroke prevention in people with atrial fibrillation: treatments and trials 93
Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis: Analysis of the ACTION CVT 92
Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia 92
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke 92
Visual experiences of Blaise Pascal 91
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation 91
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial 90
History of cardiac embolism 90
Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score 88
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both? 88
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 87
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant dta meta-analysis 87
Comparative study of venous thromboembolic prophylaxis strategies in hemorrhagic stroke: A systematic review and network meta-analysis 87
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 87
Sex-related differences in clinical characteristics, treatment and outcomes in patients with atrial fibrillation and acute ischemic stroke treated with non-vitamin-K antagonists 87
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis 87
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 86
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 85
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 85
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke 84
Pure sensory syndromes in thalamic stroke 83
Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis 83
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 82
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models 82
Characteristics of intracerebral hemorrhage associated with dual antiplatelet treatment 82
Profilassi secondaria nel paziente con attacco ischemico transitorio o ictus aterotrombotico carotideo [Secondary prevention in patients with transient ischemic attack or stroke due to carotid atherosclerosis] 81
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack 81
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 80
Predictors of severe intracerebral hemorrhage expansion 80
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage 80
Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies 78
Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study 78
Anticoagulation After Stroke in Patients With Atrial Fibrillation 78
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 77
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 76
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials 76
The turning point in stroke investigation for neurologists 75
A case of typical headache with an atypical diagnosis 74
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 74
The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS) 73
Migraine improvement after spontaneous cervical artery dissection the Italian Project on Stroke in Young Adults (IPSYS) 73
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion 72
Migraine and Cryptogenic Ischemic Stroke 71
A sudden neurological deficit in a patient with endocarditis 71
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 71
Semeiotica e gestione delle urgenze neurologiche 71
Acute stroke symptoms: Do differences exist between sexes? 70
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 70
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013] 70
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study 68
Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention? 67
The concept of ischemic penumbra in acute stroke and therapeutic opportunities 67
Seasonal variability in spontaneous cervical artery dissection 67
Totale 11.900
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.486
Totale 76.455
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 0 5 1 0 3 0 0 0 2 4
2022/20238 2 1 0 0 0 0 1 0 1 2 0 1
2023/20246 1 0 0 0 1 0 0 0 0 0 0 4
2024/20252.068 0 0 4 0 2 78 395 315 224 524 271 255
2025/202614.178 571 675 1.161 1.559 1.337 480 789 616 1.055 1.611 1.988 2.336
2026/20272.920 1.364 944 612 0 0 0 0 0 0 0 0 0
Totale 19.263